WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Ownership - Who owns Sage Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sage Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher BenecchiChief Operating Officer2025-04-10661$6.91
$4.57kSell
Christopher BenecchiChief Operating Officer2025-04-10793$6.91
$5.48kSell
Barry E. GreenePresident and CEO2025-04-104,862$6.91
$33.60kSell
Michael C. QuirkChief Scientific Officer and Interim Head of RD2025-04-10312$6.91
$2.16kSell
Michael C. QuirkChief Scientific Officer and Interim Head of RD2025-04-10424$6.91
$2.93kSell
Gregory L. ShifermanSenior Vice President General Counsel and Secretary2025-04-10176$6.91
$1.22kSell
Gregory L. ShifermanSenior Vice President General Counsel and Secretary2025-03-2479$8.21
$648.59Sell
Gregory L. ShifermanSenior Vice President General Counsel and Secretary2025-02-242,502$7.49
$18.74kSell
Gregory L. ShifermanSenior Vice President General Counsel and Secretary2025-02-13376$7.18
$2.70kSell
Gregory L. ShifermanSenior Vice President General Counsel and Secretary2025-02-13251$7.18
$1.80kSell

1 of 2

SAGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SAGE insiders and whales buy or sell their stock.

SAGE Shareholders

What type of owners hold Sage Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Steven M. Paul11.87%7,432,477$56.49MInsider
Biogen Inc9.97%6,241,473$47.44MInsider
Robert Nelsen8.75%5,482,038$41.66MInsider
Blackrock Inc7.75%4,850,717$36.87MInstitution
Vanguard Group Inc7.73%4,838,169$36.77MInstitution
Morgan Stanley7.34%4,594,355$34.92MInstitution
Bellevue Group Ag7.12%4,460,693$33.90MInstitution
Fmr LLC6.57%4,117,006$31.29MInstitution
Caligan Partners LP4.87%3,052,538$23.20MInstitution
Rtw Investments LP4.79%3,002,370$22.82MInstitution

1 of 3

SAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SAGE69.58%30.42%Net SellingNet Selling
MNMD48.11%51.89%Net SellingNet Selling
RGNX77.11%22.89%Net SellingNet Buying
UPB68.96%31.04%Net Buying
TBPH50.89%49.11%Net BuyingNet Selling
View Top Biotech Stocks

Sage Therapeutics Stock Ownership FAQ

Who owns Sage Therapeutics?

Sage Therapeutics (NASDAQ: SAGE) is owned by 81.80% institutional shareholders, 35.76% Sage Therapeutics insiders, and 0.00% retail investors. Steven M. Paul is the largest individual Sage Therapeutics shareholder, owning 7.43M shares representing 11.87% of the company. Steven M. Paul's Sage Therapeutics shares are currently valued at $56.49M.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.